Advertisement

Magen pp 137-152 | Cite as

Pharmakologie der Magensekretion und Magenmotorik

  • K.-Fr. Sewing
Chapter
Part of the Handbuch der inneren Medizin book series (INNEREN, volume 3 / 2)

Zusammenfassung

Die Pharmakologie des Magens ist unter zwei Gesichtspunkten interessant: 1. als Beeinflussung des Funktionszustandes, um Krankheiten zu behandeln oder zu erkennen und 2. unter dem Aspekt der Wirkungen von Pharmaka, die wegen Erkrankungen anderer Organe eingenommen werden, und von Genußmitteln.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Aune, S., Stadaas, J. O.: The inhibitory effect of sulpiride on pentagastrin-stimulated gastric secretion. Scand. J. Gastroent. 7, 713–715 (1972)PubMedGoogle Scholar
  2. Bachrach, W. H.: Anticholinergic drugs. Amer. J. dig. Dis. 3, 743–799 (1958)PubMedGoogle Scholar
  3. Bachrach, W. H.: Reserpine, gastric secretion, and peptic ulcer. Amer. J. dig. Dis. 4, 117–124 (1959)PubMedGoogle Scholar
  4. Barboriak, J. J., Meade, R. C.: Effect of alcohol on gastric emptying in man. Amer. J. clin. Nutr. 23, 1151–1153 (1970)PubMedGoogle Scholar
  5. Barlow, O. W., Beams, A. J., Goldblatt, H.: Studies on the pharmacology of ethyl alcohol. J. Pharmacol. exp. Ther. 56, 117–146 (1936)Google Scholar
  6. Barnes, P. C., Leonard, J. H. C.: Hypokalemic myopathy and myoglobinuria due to carbenoxolone sodium. Postgrad. med. J. 47, 813–814 (1971)PubMedCentralPubMedGoogle Scholar
  7. Barnett, C. W.: Tobacco smoking as a factor in the production of peptic ulcer and gastric neurosis. Boston med. surg. J. 197, 457–459 (1927)Google Scholar
  8. Baron, J. H., Elkeles, R. S., Lloyd-Mostyn, R. H., Watts, I.: The effect of carbenoxolone sodium on carbohydrate metabolism. In: Baron, J. H., Sullivan, F. M. (Eds.): Carbenoxolone sodium, p. 19–31. London: Butterworths 1970Google Scholar
  9. Becker, H. D., Reeder, D. D., Thompson, J. C.: Release of gastrin by alcohol in man and dogs. The Physiologist 16, 263 (1973)Google Scholar
  10. Bennett, R., Glass, G. B. J.: Effect of heteronium bromide on gastric acid secretion after histamine and on gastric emptying measured by radio-vitamin B12 as an indicator. Amer. J. Gastroent. 53, 330–338 (1970)PubMedGoogle Scholar
  11. Berstad, A.: Inhibition of peptic activity in man by carbenoxolone sodium. Scand. J. Gastroent. 7, 129–135 (1972)PubMedGoogle Scholar
  12. Berstad, A., Myren, J.: Effect of oxyphencyclimine hydrochloride on basal secretion of acid and pepsin in man. Scand. J. Gastroent. 6, 155–159 (1971)PubMedGoogle Scholar
  13. Bieck, P. R., Oates, J. A., Robison, G. A., Adkins, R. B.: Cyclic AMP in the regulation of gastric secretion in dogs and humans. Amer. J. Physiol. 224, 158–164 (1973)PubMedGoogle Scholar
  14. Bitsch, V., Kristensen, M.: Determination of peptic activity and acid in the gastric juice of patients with peptic disease before and after administration of glycopyrrolate. Acta med. scand. 180, 385–393 (1966)PubMedGoogle Scholar
  15. Black, J. W., Duncan, W. A. M., Durant, C. J., Ganellin, C. R., Parsons, E. M.: Definition and antagonism of histamine H2-receptors. Nature (Lond.) 236, 385–390 (1972)Google Scholar
  16. Black, J. W., Duncan, W. A. M., Emmett, J. C., Ganellin, C. R., Hesselbo, T., Parsons, M. E., Wyllie, J. H.: Metiamide — an orally active histamine H2-receptor antagonist. Agents and Actions 3, 133–137 (1973)PubMedGoogle Scholar
  17. Bovet, D., Staub, A.-M.: Action protectrice des éthers phénoliques au cours de l’intoxication histaminique. C. R. Séanc. Soc. Biol. 124, 547–549 (1937)Google Scholar
  18. Brewster, A. C., Lankford, H. G., Schwartz, M. G., Sullivan, J. F.: Ethanol and alimentary lipemia. Amer. J. clin. Nutr. 19, 225–228 (1966)Google Scholar
  19. Brodie, D. A., Chase, B. J.: The role of gastric acid in aspirin induced gastric irritation in the rat. Gastroenterology 53, 604–610 (1967)PubMedGoogle Scholar
  20. Brodie, D. A., Chase, B. J.: Evaluation of gastric acid as a factor in drug induced gastric hemorrhage in the rat. Gastroenterology 56, 206–213 (1969)PubMedGoogle Scholar
  21. Brody, M., Bachrach, W. H.: Antacids. I. Comparative biochemical and economic considerations. Amer. J. dig. Dis. 4, 435–460 (1959)PubMedGoogle Scholar
  22. Brömster, D.: Gastric emptying rate in gastric and duodenal ulceration. Scand. J. Gastroent. 4, 193–201 (1969)PubMedGoogle Scholar
  23. Brömster, D., Carlberger, G., Lundh, G., Möller, J., Rosén, A.: The effect of some oral anticholinergics on gastric emptying, pH and osmolarity in man. Scand. J. Gastroent. 4, 185–192 (1969)PubMedGoogle Scholar
  24. Butcher, R. W., Sutherland, E. W.: Adenosine-3′:5′-phosphate in biological materials: I. Purification and properties of cyclic-3′:5′-nucleotide phosphodiesterase and use of this enzyme to characterize adenosine-3′:5′-phosphate in human urine. J. biol. Chem. 237, 1244–1250 (1962)PubMedGoogle Scholar
  25. Bynum, T. E., Solomon, T. E., Johnson, L. R., Jacobson, E. D.: Inhibition of pancreatic secretion in man by cigarette smoking. Gut 13, 361–365 (1972)PubMedCentralPubMedGoogle Scholar
  26. Chey, W. Y., Kusakcioglu, O., Dinoso, V., Lorber, S. H.: Gastric secretion in patients with chronic pancreatitis and in chronic alcoholics. Arch. intern. Med. 122, 399–403 (1968)PubMedGoogle Scholar
  27. Chittenden, R. H., Mendel, L. B., Jackson, H. C.: A further study of the influence of alcohol and alcoholic drinks upon digestion, with special reference to secretion. Amer. J. Physiol. 1, 164–209 (1898)Google Scholar
  28. Chvasta, T. E., Cooke, A. R.: The effect of ulcerogenic drugs on the canine gastric mucosal barrier. J. Lab. clin. Med. 79, 302–315 (1972)PubMedGoogle Scholar
  29. Cohen, M. M., Debas, H. T., Holubitsky, I. B., Harrison, R. C.: Caffeine and pentagastrin stimulation of human gastric secretion. Gastroenterology 61, 440–444 (1971)PubMedGoogle Scholar
  30. Cooke, A. R.: (1) Role of adrenocortical steroids in the regulation of gastric secretion. Gastroenterology 52, 272–281 (1967)PubMedGoogle Scholar
  31. Cooke, A. R.: (2) Mucosal resistance and corticosteroids (comment). Gastroenterology 53, 506 (1967)Google Scholar
  32. Cooper, P., Knight, J. B.: Effect of cigarette smoking on gastric secretions in patients with duodenal ulcer. New Engl. J. Med. 255, 17–21 (1956)PubMedGoogle Scholar
  33. Croft, D. N.: The action of analgesic substances on the gastric mucosa. J. Pharm. Pharmacol. 18, 354–361 (1966)PubMedGoogle Scholar
  34. Cross, S., Rhodes, J., Hole, D.: Carbenoxolone: its protective action on gastric mucosa. Proc. 9th Internat. Congr. Gastroenterol., Paris 1972, S. 568cGoogle Scholar
  35. Curwain, B. P., Holton, P.: The effects of isoprenaline and noradrenaline on pentagastrin-stimulated gastric acid secretion and mucosal blood flow in the dog. Brit. J. Pharmacol. 46, 225–233 (1972)Google Scholar
  36. Davenport, H. W.: Ethanol damage to canine oxyntic glandular mucosa. Proc. Soc. exp. Biol. Med. 126, 657–662 (1967)PubMedGoogle Scholar
  37. Daves, I. A., Miller, J. H., Lemmi, C. A. E., Thompson, J. C.: Mechanism and inhibition of alcohol stimulant gastric secretion. Surg. Forum 16, 305–307 (1965)PubMedGoogle Scholar
  38. Debas, H. T., Cohen, M. M. Holubitski, I. B., Harrison, R. C.: Effect of cigarette smoking on human gastric secretion. Gut 12, 93–96 (1971)PubMedCentralPubMedGoogle Scholar
  39. Dinoso, V. P., Chey, W. Y., Lorber, S. H.: Zit. bei Iber, F. L.: Alcohol and the gastrointestinal tract. Gastroenterology 61, 120–123 (1971)Google Scholar
  40. Doll, R., Hill, I. D., Hutton, C. F., Underwood, D. J.: Clinical trial of a triterpenoid liquorice compound in gastric and duodenal ulcer. Lancet 1962 II, 793–796Google Scholar
  41. Doll, R., Jones, F. A., Pygott, F.: Effect of smoking on the production and maintenance of gastric and duodenal ulcers. Lancet 1958 I, 657–662Google Scholar
  42. Doll, R., Price, A. V., Pygott, F., Sanderson, P. H.: Continuous intragastric milk drip in the treatment of uncomplicated gastric ulcer. Lancet 1962 II, 70–73Google Scholar
  43. Domschke, W., Domschke, S., Classen, M., Demling, L.: Some properties of mucus in patients with gastric ulcer: the effect of treatment with carbenoxolone sodium. Scand. J. Gastroenterol. 7, 647–651 (1972)PubMedGoogle Scholar
  44. Dragstedt, C. A., Gray, J. S., Lawton, A. H., De Arellano, M. R.: Does alcohol stimulate gastric secretion by liberating histamine? Proc. Soc. exp. Biol. Med. 43, 26–28 (1940)Google Scholar
  45. Dragstedt, L. R., Woodward, E. R.: Gastric stasis, a cause of gastric ulcer. Scand. J. Gastroent. 5, Suppl. 6 (1970)Google Scholar
  46. Editorial: Anticholinergics and duodenal ulcer. Lancet 1970 II, 1173Google Scholar
  47. Ehrenfeld, L, Sturtevant, M.: Effect of tobacco smoking on gastric acidity. Amer. J. med. Sci. 201, 81–86 (1941)Google Scholar
  48. Eisner, M.: Gastrointestinal effects of metoclopramide in man. In vitro experiments with human smooth muscle preparations. Brit. med. J. 4, 679–680 (1968)PubMedCentralPubMedGoogle Scholar
  49. Elwin, C.E.: Some factors influencing the stimulatory effect of ethanol on gastric acid secretion during antrum application. Acta physiol. scand. 75, 12–27 (1969)PubMedGoogle Scholar
  50. Enders, A.: Die Blutdruckwirkung von Phenylalkylderivaten nach oraler Applikation. Arzneimittel-Forsch. 2, 288–298 (1952)Google Scholar
  51. Fenster, L. F., Weser, E.: Gastrointestinal disorders. In: Melmon, K. L., Morelli, H. F. (Eds.): Clinical pharmacology, p. 109–141. New York: Macmillan 1972Google Scholar
  52. Fordtran, J. S., Collyns, J. A. H.: Antacid pharmacology in duodenal ulcer: effect of antacids on postcibal gastric acidity and peptic activity. New Engl. J. Med. 274, 921–927 (1966)PubMedGoogle Scholar
  53. Franzen, G.: Untersuchungen über Alkohol. VII. Mitteilung: Alkoholwirkungen auf die Magenverdauung. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 134, 129–141 (1928)Google Scholar
  54. Fraser, P. M., Doll, R., Langman, M. J. S., Misiewicz, J. J., Shawdon, H. H.: Clinical trial of a new carbenoxolene analogue (BX24), zink sulphate, and vitamin A in the treatment of gastric ulcer. Gut 13, 459–463 (1972)PubMedCentralPubMedGoogle Scholar
  55. Geall, M. G., Phillips, S. F., Summerskill, W. H. J.: Profile of gastric potential difference in man: effects of aspirin, alcohol, bile, and endogenous acid. Gastroenterology 58, 437–443 (1970)PubMedGoogle Scholar
  56. Gerard, A.: Histochemical studies of the fundic mucosa of the stomach in dogs treated by ulcerogenic drugs. C. R. Soc. Biol. (Paris) 159, 1473 (1965)Google Scholar
  57. Geumei, A., Issa, I., El-Gindi, M., Abd-el-Samie, Y.: Beta-adrenergic receptors and gastric acid secretion. Surgery 66, 663–668 (1969)PubMedGoogle Scholar
  58. Gheorghiu, T., Frotz, H., Klein, H. J.: Experimentelle und klinische Untersuchungen zum Mechanismus der Carbenoxolon-Wirkung. Verh. dtsch. Ges. inn. Med. 19, 22 (1971)Google Scholar
  59. Gray, I.: Gastric response to tobacco smoking. Amer. J. Surg. 7, 489–493 (1929)Google Scholar
  60. Grossman, M. I., Roth, J. A., Ivy, A. C.: Pepsin secretion in response to caffeine. Gastroenterology 4, 251–256 (1945)Google Scholar
  61. Grote, I. W., Woods, M.: Studies on antacids. IV. Adsorption effects of various aluminium antacids upon simultaneously administered anticholinergic drugs. J. Amer, pharm. Ass., sci. Ed. 42, 319–320 (1953)Google Scholar
  62. Harris, J. B., Nigon, K., Alonso, D.: Adenosine-3′,5′-monophosphate: intracellular mediator for methyl-xanthine stimulation of gastric secretion. Gastroenterology 57, 377–384 (1969)PubMedGoogle Scholar
  63. Harvey, S. C.: Gastric antacids and digestants. In: Goodman, L. S., Gilman, A. (Eds.): The pharmacological basis of therapeutics, 4th ed., p. 1002–1019. New York: Macmillan 1970Google Scholar
  64. Henman, F. D.: Inhibition of peptic activity by carbenoxolone and glycyrrhetinic acid. Gut 11, 344–351 (1970)PubMedCentralPubMedGoogle Scholar
  65. Hirschowitz, B. I., Pollard, H. M., Hartwell, S. W., London, J.: The action of ethyl alcohol on gastric acid secretion. Gastroenterology 30, 244–256 (1956)PubMedGoogle Scholar
  66. Howells, T. H., Khanam, T., Kreel, L., Seymour, C., Oliver, B., Davies, J. A. H.: Pharmacological emptying of the stomach with metoclopramide. Brit. med. J. 1971 2, 558–560Google Scholar
  67. Ingelfinger, F. J.: Anticholinergic therapy of gastrointestinal disorders. New Engl. J. Med. 268, 1454–1457 (1963)PubMedGoogle Scholar
  68. Irvine, W. T., Watkin, D. B., Williams, E. S.: Mechanism by which alcohol stimulates acid secretion. Gastroenterology 39, 41–47 (1960)PubMedGoogle Scholar
  69. Jacobson, E. D.: The circulation of the stomach. Gastroenterology 48, 85–109 (1965)PubMedGoogle Scholar
  70. Jacoby, H. I., Brodie, D. A.: Gastrointestinal actions of metoclopramide. Gastroenterology 52, 676–684 (1967)PubMedGoogle Scholar
  71. Joske, R. A., Finckh, E. S., Wood, I. J.: Gastric biopsy: study of 1000 consecutive successful gastric biopsies. Quart. J. Med. 24, 269–294 (1955)PubMedGoogle Scholar
  72. Kaye, M. D., Beck, P., Rhodes, J., Sweetnam, P. M.: Gastric acid secretion in patients with duodenal ulcer treated for one year with anticholinergic drugs. Gut 10, 774–778 (1969)PubMedCentralPubMedGoogle Scholar
  73. Kaye, M. D., Rhodes, J., Beck, P., Sweetnam, P. M., Davies, G. T., Evans, K. T.: À controlled trial on glycopyrronium and 1-hyoscyamine in the long-term treatment of duodenal ulcer. Gut 11, 559–566 (1970)PubMedCentralPubMedGoogle Scholar
  74. Kern, F., Clark, G. M., Lukens, J. G.: Peptic ulceration occurring during therapy for rheumatoid arthritis. Gastroenterology 33, 25–33 (1957)PubMedGoogle Scholar
  75. Kirsner, J. B.: Facts and fallacies in the current medical therapy for uncomplicated duodenal ulcer. J. Amer. med. Ass. 187, 423–428 (1964)Google Scholar
  76. Kirsner, J. B., Ford, H.: (1) Phenylbutazone (butazolidin) studies on the stimulation of gastric secretion and formation of peptic ulcer in man. Gastroenterology 29, 1–17 (1955)PubMedGoogle Scholar
  77. Kirsner, J. B., Ford, H.: (2) Phenylbutazone (butazolidin) effect on basal gastric secretion and the production of gastroduodenal ulcerations in dogs. Gastroenterology 29, 18–23 (1955)PubMedGoogle Scholar
  78. Kirsner, J. B., Palmer, W. L.: The effect of various antacids upon hydrogen ion concentration in the gastric contents. Amer. J. dig. Dis. 7, 85–93 (1940)Google Scholar
  79. Kirsner, J. B., Palmer, W. L.: Treatment of peptic ulcer: current concepts. Amer. J. Med. 13, 615–639 (1952)PubMedGoogle Scholar
  80. Koelle, G. B.: Parasympathomimetic agents. In: Goodman, L. S., Gilman, A. (Eds.): The pharmacological basis of therapeutics, 4th ed., p. 466–477. New York: Macmillan 1970Google Scholar
  81. Konturek, S. J.: Nicotine and peptic ulcer. Pol. med. J. 46, 1765–1769 (1971)Google Scholar
  82. Konturek, S. J.: Nicotine and gastro-intestinal secretions. Acta Hepato-Gastroent. 19, 413–417 (1972)Google Scholar
  83. Konturek, S. J., Oleksy, J., Wysocki, A.: Effect of atropine on gastric acid response to graded doses of pentagastrin and histamine in duodenal ulcer patients before and after vagotomy. Amer. J. dig. Dis. 13, 792–800 (1968)PubMedGoogle Scholar
  84. Konturek, S. J., Solomon, T. E., McCreight, W. G., Johnson, L. R., Jacobson, E. D.: Effects of nicotine on gastrointestinal secretions. Gastroenterology 60, 1098–1105 (1971)PubMedGoogle Scholar
  85. Krasnow, S., Grossman, M. I.: Stimulation of gastric secretion in man by theophylline ethylenediamine. Proc. Soc. exp. Biol. Med. 71, 335–337 (1949)PubMedGoogle Scholar
  86. Krueger, L., MacIntosh, F. C.: Alcohols as a stomachic. Amer. J. dig. Dis. 4, 104–107 (1937)Google Scholar
  87. Lawrence, J. S.: Dietetic and other methods in the treatment of peptic ulcer. Lancet 1952 I, 482–485Google Scholar
  88. Leevy, C. M., Valdellon, E., Smith, F.: Nutritional factors in alcoholism and its complications. In: Israel, Y., Mardones, J. (Eds.): Biological basis of alcoholism, p. 365–382. New York, London, Sidney, Toronto: John Wiley & Sons 1971Google Scholar
  89. Levant, J. A., Walsh, J. H., Isenberg, J. I.: Stimulation of gastric secretion and gastrin release by single oral doses of calcium carbonate in man. New Engl. J. Med. 289, 555–558 (1973)PubMedGoogle Scholar
  90. Liebowitz, D., Carbone, J. V.: Effect of varying doses of reserpine on gastric secretion. New Engl. J. Med. 257, 227–228 (1957)PubMedGoogle Scholar
  91. Lipkin, M.: Carbenoxolone sodium and the rate of extrusion of gastric epithelial cells. In: Baron, J. H., Sullivan, F. M. (Eds.): Carbenoxolone sodium, p. 11–17. London: Butter-worths 1970Google Scholar
  92. Mahon, W. A.: Gut antispasmodics. Canad. med. Ass. J. 93, 121–122 (1965)PubMedCentralPubMedGoogle Scholar
  93. Maiwald, L., Weicker, U.: Veränderte Zusammensetzung des Magenschleims nach Carben-oxolonbehandlung. Z. Gastroent. 10, 17–21 (1972)Google Scholar
  94. Max, M., Menguy, R.: Influence of adrenocorticotropin, cortisone, aspirin, and phenylbutazone on the rate of exfoliation and the rate of renewal of gastric mucosal cells. Gastroenterology 58, 329–336 (1970)PubMedGoogle Scholar
  95. Menguy, R., Desbaillets, L.: (1) Role of inhibition of gastric mucous secretion in the phenomenon of gastric mucosal injury by indomethacin. Amer. J. dig. Dis. 12, 862–866 (1967)PubMedGoogle Scholar
  96. Menguy, R., Desbaillets, L.: (2) Influence of phenylbutazone on gastric secretion of mucus. Proc. Soc. exp. Biol. Med. 125, 1108–1111 (1967)PubMedGoogle Scholar
  97. Menguy, R., Masters, Y. F.: Effect of cortisone on mucoprotein secretion by gastric antrum of dogs. Pathogenesis of steroid ulcer. Surgery 54, 19–27 (1963)PubMedGoogle Scholar
  98. Mertz, D. P.: Effect of theophylline on acid secretion of stimulated gastric mucosa. Experientia (Basel) 25, 269–270 (1969)Google Scholar
  99. Miederer, S. E., Deyhle, P., Stadie, H., Klenk, M., Ottenjann, R.: Der Einfluß von Glucagon auf die durch Methylxanthine (Theophyllin) stimulierte Säure-, Elektrolyt- und Pepsinogensekretion des menschlichen Magens. Klin. Wschr. 48, 1339–1343 (1970)PubMedGoogle Scholar
  100. Milton-Thompson, G. J., Williams, J. G., Jenkins, D. J. A., Misiewicz, J. J.: Inhibition of nocturnal acid secretion in duodenal ulcer by one oral dose of Metiamide. Lancet 1974 I, 693–694Google Scholar
  101. Mitchell, A. B. S.: Duogastrone-induced hypokalemic nephropathy and myopathy with myoglobinuria. Postgrad. med. J. 47, 807–813 (1971)PubMedCentralPubMedGoogle Scholar
  102. Mitchell, R. D., Hunt, J. N., Grossman, M. I.: Inhibition of basal and postprandial gastric secretion by poldine and atropine in patients with peptic ulcer. Gastroenterology 43, 400–406 (1962)Google Scholar
  103. Monson, R. R.: Cigarette smoking and body form in peptic ulcer. Gastroenterology 58, 337–344 (1970)PubMedGoogle Scholar
  104. Myhill, J., Piper, D. W.: Antacid therapy of peptic ulcer. Part I. A mathematical definition of an adequate dose. Gut 5, 581–584 (1964)PubMedCentralPubMedGoogle Scholar
  105. Nickerson, M.: Drugs inhibiting adrenergic nerves and structures innervated by them. In: Goodman, L. S., Gilman, A. (Eds.): The pharmacological basis of therapeutics, 4th ed., p. 549–584. New York: Macmillan 1970Google Scholar
  106. Nicoloff, D. M.: Indomethacin effect on gastric secretion, parietal cell population and ulcer provocation in the dog. Arch. Surg. 97, 809–815 (1968)PubMedGoogle Scholar
  107. Norgaard, R. P., Polter, D. E., Wheeler, J. W., Fordtran, J. S.: Effect of long term anticholinergic therapy on gastric acid secretion, with observations on the serial measurement of peak histalog response. Gastroenterology 58, 750–755 (1970)PubMedGoogle Scholar
  108. Novis, B. H., Marks, I. N., Bank, S., Sloan, A. W.: The relation between gastric acid secretion and body habitus, blood groups, smoking, and the subsequent development of dyspepsia and duodenal ulcer. Gut 14, 107–112 (1973)PubMedCentralPubMedGoogle Scholar
  109. Ottenjann, R., Nitsche, R., Rösch, W.: Über den Einfluß von Theophyllin auf die durch Pentagastrin submaximal stimulierte gastrale Säuresekretion. Klin. Wschr. 49, 56–57 (1971)PubMedGoogle Scholar
  110. Packard, R. S.: Smoking and the alimentary tract. A review. Gut 1, 171–176 (1960)Google Scholar
  111. Palmer, E. D.: Gastritis: revaluation. Medicine (Baltimore) 33, 199–290 (1954)Google Scholar
  112. Pihkanen, T. A.: Neurological and physiological studies on distilled and brewed beverages. Ann. Med. exp. Fenn. 35, Suppl. 9 (1957)Google Scholar
  113. Piper, D. W.: Antacid and cholinergic drug therapy of peptic ulcer. Gastroenterology 52, 1009–1018 (1967)PubMedGoogle Scholar
  114. Piper, D. W., Fenton, B. H.: Antacid therapy of peptic ulcer. Part II. An evaluation of antacids in vitro. Gut 5, 585–589 (1964)PubMedCentralPubMedGoogle Scholar
  115. Piper, D. W., Raine, J. M.: Effect of smoking on gastric secretion. Lancet 1959 I, 696–698Google Scholar
  116. Riese, J. A.: Clinical trial of Win Gel tablets, an aluminium hydroxide-hexitol-magnesium hydroxide antacid. Curr. ther. Res. 10, 260–264 (1968)PubMedGoogle Scholar
  117. Robert, A., Nezemis, J. E.: Ulcerogenic property of steroids. Proc. Soc. exp. Biol. Med. 99, 443–447 (1958)PubMedGoogle Scholar
  118. Roberts, D. M.: Treatment of peptic ulcer by high doses of propantheline bromide. Amer. J. Gastroent. 47, 124–133 (1967)PubMedGoogle Scholar
  119. Roberts, D. M.: The effect of atropine on gastric secretory patterns in response to pentagastrin, histalog and insulin. Amer. J. Gastroent. 52, 334–344 (1969)PubMedGoogle Scholar
  120. Roberts, D. M.: Chronic gastritis, alcohol, and non-ulcer dyspepsia. Gut 13, 768–774 (1972)PubMedCentralPubMedGoogle Scholar
  121. Roth, J. A., Ivy, A. C.: (1) The effect of caffeine upon gastric secretion in the dog, cat and man. Amer. J. Physiol. 141, 454–461 (1944)Google Scholar
  122. Roth, J. A., Ivy, A. C.: (2) The synergistic effect of caffeine upon histamine in relation to gastric secretion. Amer. J. Physiol. 142, 107–113 (1944)Google Scholar
  123. Rubin, R., Pelikan, E. W., Kensler, C. J.: Effect of un-buffered and buffered acetylsalicylic acid on intragastric pH. New Engl. J. Med. 261, 1208–1212 (1959)PubMedGoogle Scholar
  124. De Saint-Blanqtjat, G., Derache, R.: Action de l’éthanol sur la physiologie gastrique. Arch. Mal. Appar. dig. 61, Suppl. 1, 97–108 (1972)Google Scholar
  125. Salter, R. H.: Aspirin and gastrointestinal bleeding. Amer. J. dig. Dis. 13, 38–58 (1968)PubMedGoogle Scholar
  126. Schnedorf, J. G., Ivy, A. C.: Effect of tobacco smoking on the alimentary tract: an experimental study of man and animals. J. Amer. med. Ass. 112, 898–904 (1939)Google Scholar
  127. Scratcherd, T., Case, R. M.: The role of cyclic adenosine-3′,5′-monophosphate (AMP) in gastrointestinal secretion. Gut 10, 957–961 (1969)PubMedCentralPubMedGoogle Scholar
  128. Sircus, W.: Carbenoxolone sodium. Gut 13, 816–824 (1972)PubMedCentralPubMedGoogle Scholar
  129. Sodeman, W. A., Augne, N. A., Pollard, H. M.: Physiology and pharmacology of belladonna therapy in acid-peptic disease. Med. Clin. N. Amer. 53, 1379–1388 (1969)PubMedGoogle Scholar
  130. Stadaas, J. O., Attne, S.: The effect of sulpiride on gastric motility. Scand. J. Gastroent. 7, 717–721 (1972)PubMedGoogle Scholar
  131. Steigman, F., Dolehide, R. H., Kaminski, L.: Effect of smoking tobacco on gastric acidity and motility of hospital controls and patients with peptic ulcer. Amer. J. Gastroent. 22, 399–409 (1954)Google Scholar
  132. Strickland, R. J., Fisher, J. M., Taylor, K. B.: Effect of prednisolone on gastric structure and function in man. Gastroenterology 56, 675–686 (1969)PubMedGoogle Scholar
  133. Sun, D. C. H.: Long-term anticholinergic therapy for prevention of recurrences in duodenal ulcer. Amer. J. dig. Dis. 9, 706–716 (1964)PubMedGoogle Scholar
  134. Taylor, R. T., Huskisson, E. C., Whitehouse, G. H., Hart, F. D., Trapnell, D. H.: Gastric ulceration occurring during indomethacin therapy. Brit. med. J. 1968 4, 734–737Google Scholar
  135. Waisbren, B. A., Hueckel, J. S.: Reduced absorption of aureomycin caused by aluminium hydroxide gel (Amphojel). Proc. Soc. exp. Biol. Med. 73, 73–74 (1950)PubMedGoogle Scholar
  136. Walan, A.: The effect of l-hyoscyamine on gastric secretion of acid and pepsin in man. Scand. J. Gastroent. 4, 157–167 (1969)PubMedGoogle Scholar
  137. Walsh, J. H., Yalow, R. S., Berson, S. A.: The effect of atropine on plasma gastrin response to feeding. Gastroenterology 60, 16–21 (1971)PubMedGoogle Scholar
  138. Werning, C., Bayer, J. M., Fischer, K, Schweikert, H. U., Siegenthaler, W.: Die Wirkung von Carbenoxolon-Natrium auf den Blutdruck, die Plasma-Renin-Aktivität und die Serumelektrolyte bei adrenalektomierten Patienten. Dtsch. med. Wschr. 97, 91–92 (1972)PubMedGoogle Scholar
  139. Woodward, E. R., Robertson, C., Ruttenberg, H., Schapiro, H.: Alcohol as a gastric secretory stimulant. Gastroenterology 32, 727–737 (1957)PubMedGoogle Scholar
  140. Wyllie, J. H., Hesselbo, T.: Inhibition of gastric secretion in man by metiamide. In: Wood, C. J., Simkins, M. A. (Eds.): International symposium on histamine H2-receptor antagonists, p. 371–382. Welwyn Garden City: Smith Kline & French Laboratories Ltd. 1973Google Scholar
  141. Wyllie, J. H., Hesselbo, T., Black, J. W.: Effects in man of histamine H2-receptor blockade by burimamide. Lancet 1972 II, 1117–1120Google Scholar
  142. Zaidi, S. H., Songh, G. B., Bajpal, R. P.: Mucous barrier in experimental phenylbutazone peptic ulceration. Indian. J. med. Res. 49, 16 (1961)Google Scholar

Copyright information

© Springer-Verlag Berlin · Heidelberg 1974

Authors and Affiliations

  • K.-Fr. Sewing
    • 1
  1. 1.TübingenDeutschland

Personalised recommendations